Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 8/20 | 0.50 |
| ▸ | SELL | P14151 | 7/20 | 0.50 |
| ▸ | AKT1 | P31749 | 2/20 | 0.45 |
| ▸ | TLR4 | O00206 | 1/20 | 0.41 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | ALPL | P05186 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALPG | P10696 | 1/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | GALK1 | P51570 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | CASP6 | P55212 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15364474 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL28604337 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL15889458 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL12225544 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL19841526 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL15568067 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL24311315 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL22343485 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL22343481 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 | |
| SCHEMBL27208843 | 1.00 | SELP (0.50) | SELPSELLAKT1TLR4SYNJ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041724-A1 | PHARMACEUTICAL DELIVERY COMPOSITIONS AND USES THEREOF | INNOVACORIUM, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250352566-A1 | RHAMNOLIPIDS FOR WOUND HEALING | STEPAN CO (US) | 2025-11-20 | — | — | US | disclosed |
| EP-3245293-B1 | PRODUCTION OF RHAMNOLIPID COMPOSITIONS | STEPAN CO (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-4204505-B1 | POLISHING COMPOSITIONS AND METHODS OF USING THE SAME | FUJIFILM ELECTRONIC MAT USA INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12410383-B2 | Process of making a treatment composition that includes a plant rosin material and related premix compositions | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-09 | — | — | US | disclosed |
| EP-3908251-B1 | PHARMACEUTICAL DELIVERY COMPOSITIONS AND USES THEREOF | INNOVACORIUM INC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12383590-B2 | Pharmaceutical delivery compositions and uses thereof | INNOVACORIUM, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250250506-A1 | HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND ALKYL SULFATE CO-SURFACTANT | STEPAN CO (US) | 2025-08-07 | — | — | US | disclosed |
| US-12371726-B2 | Process to produce mono-rhamnolipids | CONOPCO, INC. (GB) | 2025-07-29 | — | — | US | disclosed |
| US-20250228879-A1 | METHOD AND COMPOSITION FOR CONTROLLING ACNE USING RHAMNOLIPIDS | STEPAN CO (US) | 2025-07-17 | — | — | US | disclosed |
| EP-2596087-B1 | COMBINATIONS OF RHAMNOLIPIDS AND ENZYMES FOR IMPROVED CLEANING | UNILEVER PLC (GB) | 2015-12-16 | — | — | EP | disclosed |
| WO-2015091457-A1 | COMPOSITION | UNILEVER PLC (GB) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015091294-A1 | MONO-RHAMNOLIPID BASED COMPOSITIONS. | UNILEVER PLC (GB) | 2015-06-25 | — | — | WO | disclosed |
| EP-2847285-A2 | AQUEOUS COATINGS AND PAINTS INCORPORATING ONE OR MORE ANTIMICROBIAL BIOSURFACTANTS AND METHODS FOR USING SAME | Rhodia Operations (FR) | 2015-03-18 | — | — | EP | disclosed |
| US-8957129-B2 | Aqueous coatings and paints incorporating one or more antimicrobial biosurfactants and methods for using same | RHODIA OPERATIONS (FR) | 2015-02-17 | — | — | US | disclosed |
| WO-2014027249-A2 | AQUEOUS COATINGS AND PAINTS INCORPORATING ONE OR MORE ANTIMICROBIAL BIOSURFACTANTS AND METHODS FOR USING SAME | RHODIA OPERATIONS (FR) | 2014-02-20 | — | — | WO | disclosed |
| US-20130296461-A1 | AQUEOUS COATINGS AND PAINTS INCORPORATING ONE OR MORE ANTIMICROBIAL BIOSURFACTANTS AND METHODS FOR USING SAME | RHODIA OPERATIONS (FR) | 2013-11-07 | — | — | US | disclosed |
| EP-2596087-A1 | COMBINATIONS OF RHAMNOLIPIDS AND ENZYMES FOR IMPROVED CLEANING | Unilever PLC (GB) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012010406-A1 | COMBINATIONS OF RHAMNOLIPIDS AND ENZYMES FOR IMPROVED CLEANING | UNILEVER PLC (GB) | 2012-01-26 | — | — | WO | disclosed |
| EP-2410039-A1 | Rhamnolipids with improved cleaning | Unilever PLC (GB) | 2012-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228879-A1 | METHOD AND COMPOSITION FOR CONTROLLING ACNE USING RHAMNOLIPIDS | LRAT, LIPA, SGMS2 | SELP 4210/4885SELL 3229/4885AKT1 1579/4885 |
| US-20260041724-A1 | PHARMACEUTICAL DELIVERY COMPOSITIONS AND USES THEREOF | LIPA, DSG1, LIPG | SELP 637/4885SELL 1504/4885AKT1 1200/4885 |
| US-20250352566-A1 | RHAMNOLIPIDS FOR WOUND HEALING | LPCAT3, LRAT, MBOAT7 | SELP 2044/4885SELL 2391/4885AKT1 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.